Effect of High Flow Tracheostomy Device for weaning from Mechanical Ventilation
Determination of the effect of a high flow tracheostomy device on applying positive airway pressure and increasing end expiratory lung volume in patients weaning from long term mechanical ventilation
The Prince Charles Hospital
20 participants
Jul 3, 2013
Interventional
Conditions
Summary
The weaning of long term tracheostomised ICU patients from prolonged mechanical ventilation can be difficult, challenging and at a great financial cost to the health care institution. Humidified oxygen can be delivered via a humidified t-piece at up to 15 litres a minute but this is unlikely to offer any benefit in terms of generating positive airway pressure and increasing end expiratory lung volume.The High flow tracheostomy device (HFT) allows the delivery of warmed, humidified oxygen at a prescribed fraction of inspired oxygen (FiO2) at flow rates much higher than previously allowable with other delivery systems. The use of this method of oxygen and flow delivery in weaning off mechanical ventilation is becoming more common in our ICU and there is a real need to determine if this therapy generates positive airway pressure and increases end expiratory lung volume; to quantify these changes; and also to determine if this treatment has any clinically relevant benefit which will lead to improved outcomes for these patients. Electrical Impedance Topography (EIT) is a relatively new non-invasive radiation-free imaging technique which can be used easily and safely at the bedside to provide real-time dynamic images of regional lung ventilation. Changes in end-expiratory lung impedance (EELI) as measured by EIT have been shown to have a strong linear correlation with changes in end-expiratory lung volume (EELV). Therefore, it will be possible to assess both pressure and volume simultaneously within the lung. This study aims to determine if HFT has any clinically relevant benefit in weaning patients from mechanical ventilation by assessing whether this treatment provides positive airway pressure and an increase in EELV, in addition to assessing their effects on oxygenation, respiratory rate and subjective scoring of dyspnoea
Eligibility
Inclusion Criteria4
- Written informed consent
- Male or female over 18 years of age
- Tracheostomy in situ
- Mechanical ventilation time over 96hrs
Exclusion Criteria3
- Patient refusal
- Patients unable to tolerate low flow oxygen as deemed by treating doctor
- Pneumothorax
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The intervention is 15 minutes of high flow oxygen treatment at 50L/min (intervention) via Highflow Trachesotomy interface (Optiflow (TM) Tracheostomy interface and MR850 heated humidifier, Fisher & Paykel Healthcare). All oxygen therapy will humidified as per standard practice. Patients will act as their own control. The order in which the intervention is applied will be randomised. A 15 minute washout period of standard low flow treatment will occur between the intervention and standard treatment. A registered ICU nurse with over 10 years experience will apply the interventions. The study will be conducted in the ICU of The Prince Charles Hospital. Oxygen saturation will be maintained at greater than 92% or as dictated by the treating intensivist. Electrical Impedance topography (EIT) will be used to measure end expiratory lung impedance (EELI) which correlates closely with end expiratory lung volume (EELV). EIT involves placing a belt containing sensors around the patients chest patients chest. A 6Fr cannula will be placed in the tracheostomy tube to 1cm from the proximal end. This will be conducted to a pressure transducer in order to measure airway pressures.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12616001145493